Opthea Comes with Announcements regarding its new Leaders
Opthea Limited (NASDAQ: OPT; ASX: OPT), a clinical-stage biopharmaceutical company, has announced a significant change in its executive team. Dr. Megan Baldwin, the current Chief Executive Officer, will transition to the role of founder and Chief Innovation Officer, effective immediately. This strategic shift reflects the company's focus on advancing its...